Jose Luis
Alonso Romero
Asociado Ciencias de la Salud
Universidad de Navarra
Pamplona, EspañaPublications en collaboration avec des chercheurs de Universidad de Navarra (2)
2022
-
Identification of ALK-positive patients with advanced NSCLC and real-world clinical experience with crizotinib in Spain (IDEALK study)
Lung Cancer, Vol. 173, pp. 83-93
-
Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015–04 (PANGEA-Breast) study
BMC Cancer, Vol. 22, Núm. 1